Tetrabenazine
- TRADE NAMES: Nitoman (aaiPharma); Xenazine (Alliance)
- INDICATIONS: Hyperkinetic movement disorders: Huntington's chorea, hemiballismus, senile chorea, Tourette syndrome, and tardive dyskinesia
- CLASS: Vesicular monoamine transporter 2 inhibitor
- HALF-LIFE: 2–8 hours
Alcohol, Amantadine, Amiodarone, Amitriptyline, Amoxapine, Antiarrhythmics, Antibiotics, Antipsychotics, Arsenic, Chlorpromazine, Cinacalcet, Citalopram, Cyclic antidepressants, Dasatinib, Degarelix, Delavirdine, Deutetrabenazine, Dolasetron, Haloperidol, Lapatinib, Levodopa, Levofloxacin, Levomepromazine, Linezolid, Lithium, Lurasidone, MAO inhibitors, Metoclopramide, Moxifloxacin, Olanzapine, Paliperidone, Paroxetine Hydrochloride, Pazopanib, Procainamide, QT prolonging drugs, Quinidine, Reserpine, Risperidone, Sotalol, Telavancin, Telithromycin, Terbinafine, Thioridazine, Tipranavir, Voriconazole, Vorinostat, Ziprasidone, Zuclopenthixol
PREGNANCY CATEGORY: N/A
Based on animal data, may cause fetal harm
See full prescribing information for complete boxed warning.
Please login to see the rest of this drug profile
Page last updated 07/31/2023
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric
